Kevin Bunker
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Kevin Bunker
Kevin Bunker was last confirmed as COO at Zentalis Pharmaceuticals, Inc. (ZNTL) in a filing dated April 28, 2022. Zentalis Pharmaceuticals, Inc. reported in an 8-K filed September 27, 2022 that Kevin Bunker was appointed Chief Scientific Officer, effective September 26, 2022. The proxy statement of Zentalis Pharmaceuticals, Inc. reports total compensation of $5,115,956 for Kevin Bunker in fiscal 2023, including a base salary of $580,125. Disclosed compensation is on record for 5 fiscal years.
“On and effective September 26, 2022, Kevin Bunker was promoted to Chief Scientific Officer of Zentalis Pharmaceuticals, Inc. (the “Company”) and, as a result of his promotion, stepped down as Chief Operating Officer of the Company.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Start not stated–2022-04-28
Last confirmed by a filing; no departure on record
-
Zentalis Pharmaceuticals, Inc. (ZNTL)
Proxy statement
Start not stated–2024-04-29
Last confirmed by a filing; no departure on record
Company network
Recorded roles and call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2023 | Zentalis Pharmaceuticals, Inc. (ZNTL) | Former Chief Scientific Officer | $580,125 | $5,115,956 |
| 2022 | Zentalis Pharmaceuticals, Inc. (ZNTL) | Former Chief Scientific Officer | $530,602 | $5,722,062 |
| 2021 | Zentalis Pharmaceuticals, Inc. (ZNTL) | Former Chief Scientific Officer | $446,913 | $2,806,833 |
| 2020 | Zentalis Pharmaceuticals, Inc. (ZNTL) | Chief Scientific Officer | $428,771 | $6,273,594 |
| 2019 | Zentalis Pharmaceuticals, Inc. (ZNTL) | Chief Operating Officer | $360,024 | $779,434 |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.